Unknown

Dataset Information

0

Dissociated leg muscle atrophy in amyotrophic lateral sclerosis/motor neuron disease: the 'split-leg' sign.


ABSTRACT: Disproportionate muscle atrophy is a distinct phenomenon in amyotrophic lateral sclerosis (ALS); however, preferentially affected leg muscles remain unknown. We aimed to identify this split-leg phenomenon in ALS and determine its pathophysiology. Patients with ALS (n?=?143), progressive muscular atrophy (PMA, n?=?36), and age-matched healthy controls (HC, n?=?53) were retrospectively identified from our motor neuron disease registry. We analyzed their disease duration, onset region, ALS Functional Rating Scale-Revised Scores, and results of neurological examination. Compound muscle action potential (CMAP) of the extensor digitorum brevis (EDB), abductor hallucis (AH), and tibialis anterior (TA) were reviewed. Defined by CMAPEDB/CMAPAH (SIEDB) and CMAPTA/CMAPAH (SITA), respectively, the values of split-leg indices (SI) were compared between these groups. SIEDB was significantly reduced in ALS (p?TA reduction was more prominent in PMA (p?EDB), while was rather increased with clinical upper motor neuron signs (SITA). Compared to the AH, TA and EDB are more severely affected in ALS and PMA patients. Our findings help to elucidate the pathophysiology of split-leg phenomenon.

SUBMITTER: Min YG 

PROVIDER: S-EPMC7518279 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Dissociated leg muscle atrophy in amyotrophic lateral sclerosis/motor neuron disease: the 'split-leg' sign.

Min Young Gi YG   Choi Seok-Jin SJ   Hong Yoon-Ho YH   Kim Sung-Min SM   Shin Je-Young JY   Sung Jung-Joon JJ  

Scientific reports 20200924 1


Disproportionate muscle atrophy is a distinct phenomenon in amyotrophic lateral sclerosis (ALS); however, preferentially affected leg muscles remain unknown. We aimed to identify this split-leg phenomenon in ALS and determine its pathophysiology. Patients with ALS (n = 143), progressive muscular atrophy (PMA, n = 36), and age-matched healthy controls (HC, n = 53) were retrospectively identified from our motor neuron disease registry. We analyzed their disease duration, onset region, ALS Function  ...[more]

Similar Datasets

| S-EPMC5725447 | biostudies-literature
| S-EPMC6485636 | biostudies-literature
| S-EPMC6464737 | biostudies-literature
| S-EPMC7544921 | biostudies-literature
| S-EPMC6113638 | biostudies-literature
2010-03-07 | E-GEOD-19332 | biostudies-arrayexpress
| S-EPMC2844426 | biostudies-literature
| S-EPMC5839621 | biostudies-literature